The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching Antipsychotics. | Focus (Am Psychiatr Publ);14(3): 378-386, 2016 Jul. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching Antipsychotics.

Leucht, Stefan; Rossum, Inge Winter-van; Heres, Stephan; Arango, Celso; Fleischhacker, W Wolfgang; Glenthøj, Birte; Leboyer, Marion; Leweke, F Markus; Lewis, Shôn; McGuire, Phillip; Meyer-Lindenberg, Andreas; Rujescu, Dan; Kapur, Shitij; Kahn, René S; Sommer, Iris E.

Focus (Am Psychiatr Publ) ; 14(3): 378-386, 2016 Jul.

Article in En | MEDLINE | ID: mdl-31997959

ABSTRACT

(Reprinted with permission from Schizophrenia Bulletin 2015; 41(3):549-558).

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Focus (Am Psychiatr Publ) Year: 2016 Document type: Article Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Focus (Am Psychiatr Publ) Year: 2016 Document type: Article Country of publication: United States